Little information has been reported on the metabolic characteristics of the totally pancreatectomized patient or the efficacy of medical management after radical pancreatic surgery. The prospective evaluation of 49 such patients, with 31% followed for 48 or more months, forms the basis of this report. The major immediate postoperative challenge is control of diarrhea and weight stabilization. Chronically patients have an increased daily caloric requirement (mean ± SE, 56 ± 1 kcal/kg), not wholly explained by moderate steatorrhea (fecal fat excretion, 16% ± 2% of unrestricted fat intake). Despite persistent malabsorption, deficiencies in fat-soluble vitamin, magnesium, and trace element serum levels can be prevented in most patients. Pancreatogenic diabetes is characterized by (1) absence of the major glucoregulatory hormones insulin and glucagon, (2) 'brittle.' It is assumed that the diabetes is otherwise similar to the spontaneously occurring disorder in adults, requiring similar management. Pancreatic exocrine deficiency has been studied as it relates to steatorrhea but with limited information on other nutritional deficiencies. Particularly striking is the absence of information on the long-term consequences of the operation. This report concerns the prospective evaluation of 49 patients who had a total pancreatectomy as part of a resection that included a regional lymph node dissection, sympathectomy, and segmental portal vein resection with reconstruction (regional total pancreatectomy). Acute and chronic indices of malabsorption are reported. The diabetic state is characterized and its management discussed. Adverse chronic sequelae of the operation include an unusual frequency of liver disease and osteopenia; noteworthy are the absence of clinically overt diabetic microand macrovascular disease and the reasonable performance status in long-term survivors.
Little information has been reported on the metabolic characteristics of the totally pancreatectomized patient or the efficacy of medical management after radical pancreatic surgery. The prospective evaluation of 49 such patients, with 31% followed for 48 or more months, forms the basis of this report. The major immediate postoperative challenge is control of diarrhea and weight stabilization. Chronically patients have an increased daily caloric requirement (mean ± SE, 56 ± 1 kcal/kg), not wholly explained by moderate steatorrhea (fecal fat excretion, 16% ± 2% of unrestricted fat intake). Despite persistent malabsorption, de- ficiencies in fat-soluble vitamin, magnesium, and trace element serum levels can be prevented in most patients. Pancreatogenic diabetes is characterized by (1) absence of the major glucoregulatory hormones insulin and glucagon, (2) instability, and (3) frequent hypoglycemia, with the latter parameters improving with rigorous home glucose monitoring. No patient has developed clinically overt diabetic micro-or macrovascular disease. Performance status in long-term survivors has been reasonable. However adverse chronic sequelae of the operation occur and include an unusual frequency of liver disease, characterized by accelerated fatty infiltration, and osteopenia, with an 18% reduction in radial bone mineral content noted in pancreatectomized patients studied more than 5 years after surgery.
T n HE FIRST TOTAL PANCREATECTOMY in humans was performed in 1942. ' The value of this procedure in treating a variety of tumors of the pancreas has been evaluated in many reports in the intervening 47 years.'2 Little information, however, has been reported on the metabolic characteristics of the totally pancreatectomized patient or the efficacy of medical management. The diabetic state is often characterized as 'brittle.' It is assumed that the diabetes is otherwise similar to the spontaneously occurring disorder in adults, requiring similar management. Pancreatic exocrine deficiency has been studied as it relates to steatorrhea but with limited information on other nutritional deficiencies. Particularly striking is the absence of information on the long-term consequences of the operation. This report concerns the prospective evaluation of 49 patients who had a total pancreatectomy as part of a resection that included a regional lymph node dissection, sympathectomy, and segmental portal vein resection with reconstruction (regional total pancreatectomy). Acute and chronic indices of malabsorption are reported. The diabetic state is characterized and its management discussed. Adverse chronic sequelae of the operation include an unusual frequency of liver disease and osteopenia; noteworthy are the absence of clinically overt diabetic microand macrovascular disease and the reasonable performance status in long-term survivors. The study population consists of all patients who underwent a complete pancreatic resection at Memorial Sloan-Kettering Cancer Center by one surgeon (JG Fortner) during the period January 1978 to June 1988 (n = 45). Four additional patients who had the procedure earlier (1972, 1975, 1975, 1976) are included as well. The 28 men and 21 women were 54 ± 2 years in age (mean ± SE; range, 29 to 72 years) at time of surgery.
Materials and Methods

Patient Characteristics
Two patients had a standard total pancreatic resection.
The other 47 patients had a regional total pancreatectomy, which included a complete pancreatectomy, subtotal gastrectomy, duodenectomy, splenectomy, cholecystectomy with removal of the common bile duct, and regional lymph node dissection with accompanying resection of the celiac and superior mesenteric ganglia and removal of lymphatic and nerve tissues surrounding the superior mesenteric artery. A vagotomy was not done. The pancreatic portion of the portal vein was removed en bloc and reconstructed with an end-to-end anastomosis of the superior mesenteric vein to the portal vein. Details of the surgical procedure have been previously described.'3" 4 Table 1 depicts the diagnoses prompting the surgical procedures.
Management Protocol
A team approach to patient management was used, with all patients followed by the same surgical and endocrine attending physicians (JG Fortner and DR Bajorunas) for the duration of the 11-year follow-up period. The team nurse clinician provided patient education on a daily basis during the initial hospitalization and was present at every outpatient visit.
Dietary guidelines. After operation all patients were managed for up to 3 days in the intensive care unit and after their transfer to the general surgical floor, total parenteral nutrition (TPN) was maintained until adequate oral feedings were clinically feasible. Thereafter the patients were placed on a high calorie (40 to 50 kcal/kg), three-meal, three-snack diet/day, limited in sucrose calories only if the patients were maintaining weight. Additional caloric intake was encouraged by the use of lactose-free, lower osmolarity oral formula supplements and the liberal use of medium-chain triglyceride (MCT) oil. No specific dietary fat restriction was placed and the overall caloric distribution approximated 35% to 40% fat, 45% to 50% carbohydrate, and 15% to 20% protein calorie intake. In patients whose diarrhea was protracted, an empiric lactose-free diet was instituted.
Patients were discharged from the hospital only when a trend toward weight stabilization was demonstrated and calorie counts showed an intake of at least 2000 kcal/day. Following discharge all patients were maintained on the In selected patients the completeness of the pancreatic resection was verified by stimulated C-peptide levels. 26 Plasma immunoreactive glucagon (IRG) and IRG chromatographic profiles were assayed in the laboratory of Dr. Jonathan Jaspan, University of Chicago, using a double antibody radioimmunoassay technique with 30K antiserum. ' 3 In this assay cross-reactivity with glucagonlike immunoreactivity is minimal. Glucagon chromatographic profiles were obtained with a 1 X 50-cm BioGel P-30 column (Bio-Rad Laboratories, Richmond, CA), as previously described.27 '28 Data Analysis All data obtained through December 1988 was analyzed. Survival data are presented for all patients who had their procedure during the study period (n = 49). Metabolic parameters are presented for 35 of these patients. The data is expressed for every patient as the mean of all determinations obtained. The studies were begun no earlier than 6 months after the operation to avoid the influence of any postoperative surgical complications. Laboratory data are not included for terminally ill patients. However the final chemistry screening profile in four patients was obtained within 3 months of death from recurrent disease. All results are expressed as mean ± SE, unless otherwise stated.
Results
Surgical Outcome
The mean (±SE) postoperative follow-up for all patients has been 39 ± 6 months (median, 15 months; range, 1 to 174 months), with 31% ofpatients followed for 48 or more months. The seven patients who were operated on for benign disease (chronic pancreatitis) have had a mean survival time of 80 ± 24 months (median, 86 months; range, 1 to 174 months). There was one perioperative death due to intestinal ischemia. Three patients died 1 16 ± 29 months after surgery of cirrhosis of the liver (n = 2) and a cerebrovascular accident (n = 1). Three other patients are alive and well 12, 60, and 139 months after pancreatic resection.
The mean survival for the 7 patients with periampullary carcinoma was 70 ± 19 months (median, 102 months; range, 6 to 1 7 months). Three patients died of recurrent disease within 27 months of surgery, and two others died from non-neoplastic causes (hepatic/renal failure, cirrhosis) 102 and 110 months after surgery, respectively. Two patients are alive and well at 1 3 and 1 7 months.
The 31 patients with pancreatic adenocarcinoma have had a mean survival time of 17 ± 4 months (median, 13 months; range, 1 to 88 months). There were three perioperative deaths in this population. Eight other patients died of causes unrelated to their cancer diagnosis at 35 days (hypoglycemia), 5 weeks (suicide), 6 weeks (gastrointestinal bleeding), 2 months (cerebrovascular accident), 4 months (sepsis), 6 months (sepsis), 8 months (pulmonary embolus), and 16 months (undetermined cause) after surgery. Fourteen patients died of recurrent disease 14 ± 2 months (median survival, 14 months) after pancreatic resection. Six patients are alive without evidence of disease 6, 24, 25, 48, 83, and 88 months after their pancreatectomy. The survival experience in the larger number of patients with adenocarcinoma ofthe head ofthe pancreas undergoing a curative total or subtotal regional pancreatectomy is the subject of a recent review. 29 The mean follow-up for the 35 patients surviving for more than 6 months after surgery is 53 ± 8 months (median, 26 months; range, 8 to 174 months). Of these 89% have been followed for more than 1 year and 37% have been followed for more than 5 years.
Nutritional Status
The mean preillness weight of the study patients was 118% ± 3% of their ideal body weight (IBW thought that their meal capacity exceeded their prepancreatectomy pattern.
For the patients as a whole, the outpatient weight at last follow-up was 99% ± 4% IBW. Of the patients who survived more than 18 months after their pancreatic resection, the mean weight change from their hospital discharge weight was +2.2 ± 2.2 kg. In seven weight-maintaining patients, adherence to the recommended highcalorie diet was assessed by a review of food diaries and recall histories, and 3-day food records were submitted for computer analysis to assess nutritional soundness as well as the actual composition ofthe diets ingested. Caloric intake ranged between 2500 and 5300 kcal/day (mean, 56 ± 1 kcal/kg; range, 36 to 74 kcal/kg), was identical to the distribution prescribed, and was not deficient in any essential nutrient.
Selected parameters ofliver function for all patients are depicted in Table 2 . Elevated levels of serum glutamicoxaloacetic transaminase (SGOT/AST) and alkaline phosphatase were seen in virtually all the patients. Total protein levels were normal in all patients, but in one half ofthe patients serum albumin levels remained persistently decreased.
Malabsorption
Nine patients were studied for their ability to absorb carbohydrates by the standard D-xylose test. The mean urinary 5-hour excretion of D-xylose was 6.5 ± 0.7 g, with a range of 3.5 to 10.7 g. All but one patient demonstrated normal carbohydrate absorption. Table 3 depicts the 72-hour fecal fat excretion data obtained in 15 totally pancreatectomized patients. As noted, on a diet unrestricted in fat calories, the mean 24-hour fecal fat excretion was 16% ± 2% of dietary fat intake. No correlation could be found between the amount of dietary fat ingested and the degree ofsteatorrhea noted (r = 0. 13).
Mean serum fat-soluble vitamin, magnesium, and trace element levels were within the normal range (Table 4) (n = 4), and zinc (n = 1) were noted, despite multivitamin and pharmacologic vitamin D supplementation in all patients. The prothrombin time was normal in all patients except in whom severe hepatic insufficiency supervened, and no patient required supplemental vitamin K administration.
While the 24-hour urinary calcium excretion was normal in all patients, mean serum calcium levels were subnormal in nine patients. Furthermore the mean serum calcium level in the pancreatectomized patients, 2.32 ± 0.03 mmol/L (9.3 ± 0.1 mg/dL), was at the lower limits of normal for our laboratory, undoubtedly reflecting the prevailing lowered serum albumin level.
In 10 men and three women, bone densitometry values were obtained during the postpancreatectomy follow-up period; this measurement was repeated at variable intervals in eight patients. The mean radial bone mineral content determinations in pancreatectomized men and women, expressed as a percentage ofthat obtained in ageand sex-matched normal subjects and depicted according to when the measurement was obtained after the surgical resection, are shown in Figure 1 . While the bone density obtained in patients within 2 years after surgery appeared well maintained, patients who were studied more than 5 years after pancreatectomy had a mean reduction in bone mineral content of 17.6% compared to controls. section, and in every instance the levels were undetectable (less than 0.02 nmol/L). This finding confirmed the completeness of the surgical procedure.
Pancreatogenic
Glucagon immunoreactivity and chromatographic profiles in pancreatectomized humans. Verified by chromatographic profiling in every instance, 3500-Mr glucagon was virtually absent in 18 pancreatectomized patients: for the group as a whole, 3500-Mr IRG comprised 1% to 2% ofthe total recovered IRG (Fig. 2) . This pancreatic plasma IRG fraction was not stimulated by oral protein or intravenous arginine.
Glycemic lability. A pilot program of intensive home glucose monitoring was conducted to (1) assess the degree of diabetic instability existing in this population, (2) '48 This has been confirmed by a study using Biostator glucose-controlled insulin infusion system (Life Science Instruments, Ulm, Germany) and identical inpatient dietary regimens: following total pancreatectomy, a significant and substantial (tz35%) decrease in insulin requirements was noted compared to patients with subtotal pancreatectomy or IDDM. 49 The locus of enhanced insulin responsiveness does not appear to be peripheral tissues. While enhanced peripheral glucose uptake in response to insulin was reported in patients with pancreatogenic diabetes,50 more recent studies in well-characterized completely pancreatectomized patients have demonstrated significant insulin resistance in this population, comparable to that seen in patients with IDDM.5152 Indeed basal glucagon replacement induced a further significant reduction in tissue insulin responsiveness. 53 The primacy of glucagon in the maintenance of postabsorptive glucose concentrations is well established. Where the completeness of the surgical procedure was established, studies using column chromatography have detected absent or markedly reduced 3500-Mr glucagon in totally pancreatectomized patients.28'54 Impaired counter-regulatory hormone responsiveness has been demonstrated in these patients; two separate laboratories have found no increase of glucagon and a reduced55 or delayed56 epinephrine response to insulin-induced hypoglycemia. Certain metabolic features in this diabetic state are consistent with a chronic lack of biologically active pancreatic glucagon as well: the delayed increase of blood glucose and ketone bodies after cessation ofinsulin therapy,57 the absence of an increase in blood glucose during arginine infusion,58'59 and the abnormally elevated concentrations of the major glucogenic amino acids that decrease with physiologic glucagon replacement.43'49'60'6' Furthermore pancreatectomized patients have an exaggerated hyperglycemic response to glucagon administration compared to that seen in comparably insulin-deficient patients with IDDM, suggesting that chronic glucagon deficiency enhances sensitivity to exogenous glucagon. 43 It would appear, therefore, that impaired regulation of hepatic glucose production subsequent to surgically induced pancreatic alpha cell insufficiency is a probable cause for the frequent hypoglycemia seen in these patients. Whether glucagon replacement therapy in this population would reduce the incidence of this morbid complication remains an intriguing therapeutic option worthy of further study.
An uncommon but worrisome finding in prolonged follow-up of totally pancreatectomized patients has been the development of accelerated lipid accumulation in the liver, with end-stage liver disease as a cause ofdeath noted in three such patients in this study. This complication has been described as well in experimental pancreatectomized animals.62 '63 While poorly controlled diabetes, weight loss, and malabsorption can be contributing factors, the severity ofhepatic steatosis noted in patients who have been in reasonable diabetic control suggests additional pathogenic mechanisms. Preliminary information suggests that the storage triglycerides are not dietary in origin but result from altered hepatic metabolism. The impact of the altered hormonal milieu of the postpancreatectomy state on hepatic lipogenesis is now being studied in our laboratory.
